The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.
about
Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.Pathogenesis beyond the cancer clone(s) in multiple myeloma.Factors associated with an increased risk of vertebral fracture in monoclonal gammopathies of undetermined significance.Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years.The spectrum of somatic mutations in monoclonal gammopathy of undetermined significance indicates a less complex genomic landscape than that in multiple myeloma.MGUS to myeloma: a mysterious gammopathy of underexplored significance.Monoclonal gammopathy of renal significance: Diagnostic workup.Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity.Vitamin D and plasma cell dyscrasias: reviewing the significance.Autoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.Monoclonal gammopathy of undetermined significance (MGUS) as viewed by haematology healthcare professionals.Management of Patients With Hepatitis C Virus, Monoclonal Gammopathy of Undetermined Significance, and Multiple Myeloma.p16+ Squamous cell carcinoma in situ masquerading as genital psoriasis.Monoclonal IgM Gammopathy and Waldenström's Macroglobulinemia.Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management.Advances in the understanding of IgM monoclonal gammopathy of undetermined significance.How I manage monoclonal gammopathy of undetermined significance.Management protocols for chronic heart failure in India.
P2860
Q34525834-318717DF-3F61-4CA6-B2B0-7FE3440AD5D4Q34649034-EB0B9BA2-DE56-4A61-874B-3F2E31ABCD18Q35607266-54E702B1-296A-4136-900C-19389AC6516CQ36022586-98302005-EEDC-445D-9FE2-634D59AAFB65Q36115686-6D3F5D40-FEE7-4AD7-A30C-88828B4F4C1DQ38760679-F60783F5-5A84-4785-B886-8FBEDE79D6ACQ38979865-32618B67-325F-403C-A413-DA167EFA4A05Q39186665-F387F45E-1F89-428B-859E-F1A9677CB890Q39251479-EA93D7C8-DF1A-429D-A157-CE78316545A4Q39304767-D44ED9B9-EB6B-450B-ACC2-1AFF0F54DAB2Q39434973-33BFB7D0-7380-4FC6-A68B-7C7AF0AF41B8Q40051054-1D9B07FA-C3FF-4E1B-B558-FC8CD5C4A1FCQ40106713-1F498B44-4FE6-43FB-B944-565CE951E47EQ47109218-11435886-180B-4C11-B75D-9FF87D669D0EQ47134329-D8527644-5862-45B3-B4C4-AC6B0A0F6B24Q47642719-3425921A-A944-48D1-BD46-33A5858DB2B2Q48109341-20610081-BBFA-42BD-84D0-289684BC49F0Q48221793-A6C8B8D9-8BC8-4C21-A5A9-EC0182A5D364Q49887663-B9BCC89C-29DE-4C03-819A-10838E7351B4
P2860
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
The clinical relevance and man ...... the European Myeloma Network.
@ast
The clinical relevance and man ...... the European Myeloma Network.
@en
type
label
The clinical relevance and man ...... the European Myeloma Network.
@ast
The clinical relevance and man ...... the European Myeloma Network.
@en
prefLabel
The clinical relevance and man ...... the European Myeloma Network.
@ast
The clinical relevance and man ...... the European Myeloma Network.
@en
P2093
P2860
P50
P1433
P1476
The clinical relevance and man ...... the European Myeloma Network.
@en
P2093
Anders Waage
European Myeloma Network
Evangelos Terpos
Henk M Lokhorst
Henrik Gregersen
Hermann Einsele
Martina Kleber
Monika Engelhardt
Niels W C J van de Donk
Orhan Sezer
P2860
P304
P356
10.3324/HAEMATOL.2013.100552
P50
P577
2014-03-21T00:00:00Z